• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

All Aboard for Norfolk Southern After a Pullback

Let's check out the charts and indicators on the railroad.
By BRUCE KAMICH
Feb 03, 2021 | 12:39 PM EST
Stocks quotes in this article: NSC

For his final "Executive Decision" segment of Mad Money Tuesday evening, Jim Cramer checked in with Jim Squires, chairman and CEO of Norfolk Southern Corp. (NSC) , the railroad that posted a 16-cent-a-share earnings beat when it reported last week.

Squires said the Norfolk Southern has made a remarkable transformation over the years. When the railroad first started, 30% of their volume was coal, but now, the company transports the goods to support our consumer economy.

When asked how they've weathered the pandemic, Squires said after taking an initial hit, Norfolk Southern was able to move quickly to cut costs and increase productivity.

Let's check out the charts and indicators.

In the daily bar chart of NSC, below, we can see that prices have doubled from the March nadir. Prices are still in an uptrend but just a fraction above the now flat 50-day moving average line. The 200-day moving average line is still positive and intersects down around $208.

The On-Balance-Volume (OBV) line shows a rise from March but also a slight decline from early January suggesting a small shift from aggressive buying towards more aggressive selling. The Moving Average Convergence Divergence (MACD) oscillator is pointed down and close to the zero line. We may see a sell signal in the days ahead.

In the weekly bar chart of NSC, below, we can see a mixed picture. Prices are still in a longer-term uptrend and are trading above the rising 40-week moving average line.

The weekly OBV line has been stalled since September suggesting a balance between buyers and sellers. The MACD oscillator has been "rolling over" the past few months and tells us that the strength of the uptrend is waning.

In this daily Point and Figure chart of NSC, below, we can see a price target of $274 being projected. A trade at $233 could start to weaken the picture.

In this weekly Point and Figure chart of NSC, below, the software is projecting a potential price target in the $347 area.

Bottom-line strategy: A general, broader market decline could drag NSC lower in the weeks ahead. With bullish Point and Figure charts (above) a pullback of modest proportions (think the $220 area) may turn out to be a buying opportunity. Be patient.

Norfolk Southern is a holding in TheStreet's Trifecta Stocks portfolio. Click here to learn more about this portfolio, trading ideas and market commentary product.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Transportation | Mad Money | Executive Interview

More from Stocks

You Could Say I'm 'Fed' Up With These June Minutes

Jim Collins
Jul 7, 2022 12:30 PM EDT

From one logic-defying FOMC statement to the next, I'm not sure what I'm even reading at this point. But I do know how I'm investing.

As Harmony Biosciences Breaks Out to a New High, What's Next?

Bruce Kamich
Jul 7, 2022 12:20 PM EDT

Here's where traders could go long.

7 Biotech Stocks I'm Buying As They Lead a Market Bounce

James "Rev Shark" DePorre
Jul 7, 2022 11:56 AM EDT

It has been a mistake to trust momentum to last in this environment.

Here's Where Shares of Walmart Are Attracting Buyers

Bruce Kamich
Jul 7, 2022 11:45 AM EDT

Only nimble traders need apply.

Kass: Why I'm Aggressively Buying Bank and Brokerage Stocks

Doug Kass
Jul 7, 2022 11:30 AM EDT

For me, it's the time to be an opportunistic buyer

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 09:41 AM EDT STEPHEN GUILFOYLE

    Reweighting Portfolio Positions Through 5 Trades

    Check out what we're doing in the TheStreet's Stoc...
  • 12:01 PM EDT PAUL PRICE

    A Recent Director Buy in Children's Place (PLCE)

    Four of the most recent insider trades in Children...
  • 07:34 AM EDT PAUL PRICE

    A $525,000 Vote of Confidence on Macerich (MAC)

  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login